Summary: This study developed an anti-DWORF antibody capable of recognizing the canine protein and revealed reduced DWORF expression in Duchenne muscular dystrophy (DMD) dogs, thus laying the groundwork for DWORF-based gene therapy to treat DMD. The gene discussed is STRIT1; the disease is Duchenne muscular dystrophy.